A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants.
Elenge DM, Heo JS, Kim SS, Kim YK, Lee JH, Xavier S, Bahar E, Dos Santos G, Guignard A.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2406060. doi: 10.1080/21645515.2024.2406060. Epub 2024 Oct 8.
The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins.
Robbins JB, Schneerson R, Trollfors B, Sato H, Sato Y, Rappuoli R, Keith JM.
J Infect Dis. 2005 Jan 1;191(1):81-8. doi: 10.1086/426454. Epub 2004 Nov 30.
Clinical trials of the Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine.
Lepow M.
Pediatr Infect Dis J. 1987 Aug;6(8):804-7. doi: 10.1097/00006454-198708000-00042.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
Peterson JT, Zareba AM, Fitz-Patrick D, Essink BJ, Scott DA, Swanson KA, Chelani D, Radley D, Cooper D, Jansen KU, Dormitzer PR, Gruber WC, Gurtman A.
J Infect Dis. 2022 Jun 15;225(12):2077-2086. doi: 10.1093/infdis/jiab505.
Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme.
Coursaget P, Yvonnet B, Relyveld EH, Barres JL, Diop-Mar I, Chiron JP.
Dev Biol Stand. 1986;65:169-75.
Safety and immunogenicity of a diphtheria-tetanus-pertussis vaccine containing an acellular pertussis component.
Badgett JT, Rodgers GC Jr.
South Med J. 1987 Sep;80(9):1075-8. doi: 10.1097/00007611-198708090-00002.
Identification of Formaldehyde-Induced Modifications in Diphtheria Toxin.
Metz B, Michiels T, Uittenbogaard J, Danial M, Tilstra W, Meiring HD, Hennink WE, Crommelin DJA, Kersten GFA, Jiskoot W.
J Pharm Sci. 2020 Jan;109(1):543-557. doi: 10.1016/j.xphs.2019.10.047. Epub 2019 Oct 31.
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
Eskola J, Peltola H, Takala AK, Käyhty H, Hakulinen M, Karanko V, Kela E, Rekola P, Rönnberg PR, Samuelson JS, et al.
N Engl J Med. 1987 Sep 17;317(12):717-22. doi: 10.1056/NEJM198709173171201.
Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).
[No authors listed]
MMWR Recomm Rep. 2000 Nov 17;49(RR-13):1-8.
Preliminarily evaluation the safety and immunogenicity of tetanus, reduced diphtheria and acellular pertussis (five components) combined vaccine, adsorbed (Tdcp) in participants aged 6 years and above: a blinded and randomised, and controlled phase I clinical trial.
Liu X, Wei C, Huang H, Wan J, Li Y, Wang F, Li S, Wang Y, Wang X, Wang X, Sui X, Gou J, Zhu T, Ma X, Hu W.
Front Immunol. 2025 Sep 5;16:1616574. doi: 10.3389/fimmu.2025.1616574. eCollection 2025.
